- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Falling mammography ratecould lead to future cancers
Breast cancer screening rates are declining,according to a recent study by the Centers forDisease Control and Prevention.
Breast cancer screening rates are declining, according to a recent study by the Centers for Disease Control and Prevention.
CDC researchers analyzed mammography screening utilization for each U.S. state and correlated that with the state's respective breast cancer incidence rate. Although they saw a breast cancer incidence rate reduction from 2000 to 2006, investigators also found a slight decline in mammo use in two-thirds of the states during the same period. Findings were published in the February issue of the American Journal of Roentgenology. A commentary by radiologist Dr. Ruth C. Carlos warned that the trend could lead to the erosion of screening services and preventive care.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
